Sponsor of the Day:
Jerkmate
https://www.benzinga.com/m-a/26/01/49794479/whats-going-with-cancer-biotech-erasca-stock-on-thursday
What's Going With Cancer Biotech Erasca Stock On Thursday? - Erasca (NASDAQ:ERAS) - Benzinga
Jan 8, 2026 - Erasca stock jumps then drops after reports link it to AbbVie and a possible Revolution Medicines buyout.
thursday nasdaqgoingcancerbiotecherasca
https://www.biopharmadive.com/news/fda-tavneos-erasca-revolution-rocket-voucher-janux/818517/
FDA claims Amgen drug data were ‘manipulated’; Erasca slides despite ‘home run’ results | BioPharma...
Tavneos’ original developer hid a study analysis and then altered data, the FDA alleged. Elsewhere, Erasca’s RAS drug was met with skepticism and Rocket Pharma...
drug dataslides despiteresults biopharmafdaclaims
https://www.statnews.com/2026/04/28/biotech-news-boehringer-drug-looks-efficacious-but-more-data-needed/
Novartis, Boehringer, Eli Lilly, Erasca: Readout Newsletter
Apr 28, 2026 - Today's biotech news covers Eli Lilly's deal with Profluent, Erasca's RAS-targeting cancer pill, and Boehringer's obesity drug
eli lillyreadout newsletternovartisboehringererasca